Overview

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The study will compare the efficacy and safety of Brivaracetam with placebo in patients with Unverricht- Lundborg Disease (ULD).
Phase:
Phase 3
Details
Lead Sponsor:
UCB Pharma
Treatments:
Brivaracetam